Generic Revlimid Flounders Amid Successful Q2 Performance At Sun

Firm’s US Unit Dropped 9% Sequentially Due To Lack Of Lenalidomide Contributions

 
• By Chloe Kent
  
Orange -9% displayed against purple background
Declining sales of generic Revlimid caused a 9% drop to Sun's US business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products